Anaplerotic Therapy Using Triheptanoin for Patients With Glycogen Storage Disease Type I

Von Gierke disease

A Study of Adeno-Associated Virus Serotype 8-Mediated Gene Transfer of Glucose-6-Phosphatase in Patients With Glycogen Storage Disease Type Ia (GSDIa) A Study of mRNA-3745 in Participants With Glycogen Storage Disease Type 1a (GSD1a) Prospective Cohort Study of Children With GSD1b Receiving Empagliflozin Retrospective Study of Glucose Monitoring for Glycemic Control in Patients With GSDIa Endogenous Glucose Production in Patients With Glycogen Storage Disease Type Ia Glycosade v UCCS in the Dietary Management of Hepatic GSD Biomarker for Glycogen Storage Diseases (BioGlycogen) Study of the Relationship Between Glycogen Storage Disease Type Ia and Inflammatory Bowel Disease Overnight Feeding Study in Glycogen Storage Disease Type 1 Long-Term Follow-up to Evaluate the Safety and Efficacy of Adeno Associated Virus (AAV) Serotype 8 (AAV8)-Mediated Gene Transfer of Glucose-6-Phosphatase (G6Pase) in Adults With Glycogen Storage Disease Type Ia (GSDIa) Anaplerotic Therapy Using Triheptanoin for Patients With Glycogen Storage Disease Type I Safety and Dose-Finding Study of DTX401 (AAV8G6PC) in Adults With Glycogen Storage Disease Type Ia (GSDIa) Comparison of the Effect of a Novel Starch (Glycosade) Versus Gastrostomy Tube-Dextrose Infusion on Overnight Euglycaemia Control in Children With Glycogen Storage Disease Type I: Open Label Demonstration Trial Safety, Efficacy Evaluation of Empagliflozin Administration for Neutropenia in Glycogenosis Type 1b and G6PC3 Deficiency The Use of Uncooked Sweet Polvilho to Treat Hepatic Glycogen Storage Diseases Clinical Evaluation of a Non-Invasive Hypoglycemia Detector in a Glycogen Storage Disease Population